Your browser does not support JavaScript!


1. Madisch, Ahmed, et al. "Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial." Alimentary pharmacology & therapeutics 19.3 (2004): 271-279. Study funded by Steigerwald Arzneimittelwerk, GmbH

2. Von Arnim, Ulrike, et al. "STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study." The American journal of gastroenterology 102.6 (2007): 1268. Study funded by Steigerwald Arzneimittelwerk, GmbH

3. Ottillinger, Bertram, et al. "STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders." Wiener Medizinische Wochenschrift 163.3-4 (2013): 65-72.

4. Abdel-Aziz, Heba, et al. "Evaluating the multitarget effects of combinations through multistep clustering of pharmacological data: the example of the commercial preparation iberogast." Planta medica 83.14/15 (2017): 1130-1140.

5. WHO Monographs on Medicinal Plants Commonly Used in the Newly Independent States (NIS). 2010. Accessed on 12 Feb 2019 at:

6. Mahboubi, Mohaddese. "Caraway as Important Medicinal Plants in Management of Diseases." Natural products and bioprospecting (2018): 1-11.

7. Wagner, H. "Multitarget therapy–the future of treatment for more than just functional dyspepsia." Phytomedicine 13 (2006): 122-129.

8. Gastroenterological Society of Australia and Digestive Health Foundation. Information about irritable bowel syndrome. Available from: Information/IBS.pdf Accessed Nov 2019

9. Irritable bowel syndrome diagnosis & management, The Gut Foundation. Accessed Nov 2019

10. Australian Psychological Society Stress and wellbeing in Australia survey 2015. Page 5 and 16